anti-CD19 CAR T cell therapy Clinical Trials
3 recruitingBiologic
Phase 13Phase 23
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease
Systemic Lupus ErythematosusDermatomyositisPolymyositis+1 more
Miltenyi Biomedicine GmbH24 enrolled1 locationNCT06347718
Recruiting
Phase 1Phase 2
Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Sjogren SyndromeSystemic Lupus ErthematosusSystemic Sclerosis (SSc)+3 more
Peking University Third Hospital9 enrolled1 locationNCT06828042
Recruiting
Phase 1Phase 2
Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL
Relapse/Refractory B-cell Acute Lymphoblastic Leukemia
Kara Yakhteh Tajhiz Azma Company5 enrolled1 locationNCT06635330